IP Verse

Elkington And Fife competitive analysis

Explore the latest publications and patents granted to Elkington And Fife, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Elkington And Fife against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3359572	Method For Treating Multiple Sclerosis	F HOFFMANN LA ROCHE	Aug 27, 2025
EP3509637	Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor X	CHUGAI SEIYAKU KABUSHIKI KAISHA	Aug 27, 2025
EP3135287	Preparation Containing Tetracyclic Compound At High Dose	CHUGAI SEIYAKU KABUSHIKI KAISHA	Aug 20, 2025
EP3324956	Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 Receptor	ANAVEX LIFE SCIENCES	Jun 12, 2025
EP4014976	Aprocitentan For Use In The Treatment Of Hypertension And Related Diseases In Combination With Angiotensin Converting Enzyme Inhibitor (Ace) Or Angiotensin Receptor Blocker (Arb)	IDORSIA PHARMACEUTICALS	May 29, 2025
EP3815684	Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy	AMARIN PHARMACEUTICALS IRELAND	May 9, 2025
EP3799909	Nasal Delivery Devices	OPTINOSE	Apr 10, 2025
EP4005555	Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations	JANSSEN PHARMACEUTICA	Feb 14, 2025
EP4056176	Methods Of Reducing The Risk Of Cardiovascular Events In A Subject	AMARIN PHARMACEUTICALS IRELAND	Jan 24, 2025
EP3090730	Novel Pharmaceutical Composition	NOVARTIS	Jan 10, 2025

Discover the latest PTAB cases involving Elkington And Fife, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Elkington And Fife with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
ELKINGTON AND FIFE	87	-	-	-	Highly Aggressive
AMARIN PHARMACEUTICALS IRELAND	-	15	-	1	Non-Active
F HOFFMANN LA ROCHE	16	140	-	-	Defensive
NOVARTIS	6	406	-	21	Defensive